The University of Chicago Header Logo

Connection

Jay Koyner to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Jay Koyner has written about Angiogenesis Inhibitors.
Jay Koyner
Connection Strength
0.031
Angiogenesis Inhibitors
  1. A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction. Clin Pharmacol Ther. 2017 Aug; 102(2):313-320.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.